Market Access/ News/ News Teva faces EU antitrust probe over MS drug Copaxone Richard Staines Copaxone, multiple sclerosis, patent, Teva 0 Comment The European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company Share X Teva faces EU antitrust probe over MS drug Copaxone https://pharmaphorum.com/news/teva-faces-eu-antitrust-probe-over-ms-drug-copaxone/
